Private company

Avid Bioservices, Inc.

Last updated Oct 16, 2026.

Overview

$139.9MRevenue, fiscal 20242
-$140.8MNet income, fiscal 20242
  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE3
  • Business address14191 Myford Road, Tustin, Ca 927803
  • Filer categoryAccelerated filer3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

5.2%Gross margin2
-13.3%Operating margin2
-100.6%Net margin2
-6.3%Revenue growth, 20242
-231.2%Return on equity2
0.89×Debt to equity2
-$20.9MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue48¢$132.6M
  • Selling, general and admin9¢$26.0M
  • Interest2¢$4.3M
  • Income tax41¢$113.8M

Out of $139.9M in revenue.2 The company lost money this year.

Where each dollar of operating cash went, fiscal 2024

  • Capital spending100¢$31.8M

Out of $11.0M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.2

Financial statements

Revenue456782$139.9M in 2024+143% since 2017
0$50.0M$100.0M$150.0M2017: $57.6M$57.6M20172018: $53.6M$53.6M2018−7%2019: $53.6M$53.6M2019−0%2020: $59.7M$59.7M2020+11%2021: $95.9M$95.9M2021+61%2022: $119.6M$119.6M2022+25%2023: $149.3M$149.3M2023+25%2024: $139.9M$139.9M2024−6%
Gross profit456782$7.3M in 2024−62% since 2017
-$10.0M0$10.0M$20.0M$30.0M$40.0M2017: $19.4M$19.4M20172018: -$2.9M-$2.9M20182019: $7.2M$7.2M20192020: $3.9M$3.9M2020−46%2021: $29.3M$29.3M2021+645%2022: $36.6M$36.6M2022+25%2023: $31.5M$31.5M2023−14%2024: $7.3M$7.3M2024−77%
Operating income456782-$18.7M in 2024
-$30.0M-$20.0M-$10.0M0$10.0M$20.0M2017: $1.3M$1.3M20172018: -$20.6M-$20.6M20182019: -$5.6M-$5.6M2019−73%2020: -$10.9M-$10.9M2020+95%2021: $12.2M$12.2M20212022: $15.4M$15.4M2022+26%2023: $3.6M$3.6M2023−77%2024: -$18.7M-$18.7M2024
Net income456782-$140.8M in 2024+400% since 2017
-$200.0M-$100.0M0$100.0M$200.0M2017: -$28.2M-$28.2M20172018: -$21.8M-$21.8M2018−23%2019: -$4.2M-$4.2M2019−81%2020: -$10.5M-$10.5M2020+148%2021: $11.2M$11.2M20212022: $127.7M$127.7M2022+1039%2023: $259.0K$259.0K2023−100%2024: -$140.8M-$140.8M2024
Fiscal year20172018201920202021202220232024
Revenue$57.6M4$53.6M5$53.6M6$59.7M7$95.9M8$119.6M2$149.3M2$139.9M2
Cost of revenue$38.3M4$56.5M4$46.4M4$55.8M7$66.6M8$82.9M2$117.8M2$132.6M2
Gross profit$19.4M4-$2.9M5$7.2M6$3.9M7$29.3M8$36.6M2$31.5M2$7.3M2
Research and development$28.3M11
Selling, general and admin$18.1M4$16.5M5$12.8M6$14.5M7$17.1M8$21.2M2$27.9M2$26.0M2
Operating income$1.3M4-$20.6M5-$5.6M6-$10.9M7$12.2M8$15.4M2$3.6M2-$18.7M2
Interest$11.0K6$8.0K7$1.2M8$2.7M2$3.0M2$4.3M2
Income tax$04$05-$284.0K6$07$08-$115.0M2$1.3M2$113.8M2
Net income-$28.2M4-$21.8M5-$4.2M6-$10.5M7$11.2M8$127.7M2$259.0K2-$140.8M2
Earnings per share-$0.166-$0.277$0.068$2.082$0.002-$2.232
Earnings per share (diluted)-$0.166-$0.277$0.068$1.842$0.002-$2.232

Compare Avid Bioservices, Inc. with another company

Former names

  • PEREGRINE PHARMACEUTICALS INCDec 11, 2000 to Dec 26, 20173
  • TECHNICLONE CORP/DE/Oct 3, 1997 to Jul 31, 20003
  • TECHNICLONE INTERNATIONAL CORPDec 14, 1995 to Feb 11, 19973

Recent filings

  1. Feb 7, 20254
  2. Feb 7, 20254
  3. Feb 7, 20254
  4. Feb 7, 20254
  5. Feb 7, 20254
  6. Feb 7, 20254
  7. Feb 7, 20254
  8. Feb 7, 20254
  9. Feb 7, 20254
  10. Feb 7, 20254
  11. Feb 7, 20254
  12. Feb 5, 20258-K
  13. Feb 5, 20258-K/A 8-K
  14. Jan 30, 20258-K
  15. Jan 29, 20254

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1